Armira
Armira is a Munich-based investment holding founded in 2008 by Alexander Schemann that invests permanent capital from entrepreneur families and long-term institutions in majority stakes in Mittelstand companies (EUR 20-200m tickets, DACH and Northern Italy) alongside Armira Growth (EUR 10-100m growth capital, Fund I of EUR 200m) and Armira Opportunities minority investments. The platform manages around EUR 5bn; its latest flagship fundraising closed above hard cap in November 2025 with EUR 1bn deployable including co-investments.
Key facts
Recent exits
Coverage notes
3 funds tracked, 29 portfolio companies (23 active · 6 realized). Verified weekly from public filings and deal announcements.
Sector breakdown
29 companiesFunds & portfolio
Every fund Armira has raised, with its portfolio companies. Hand-checked from public filings.
Armira IIIBuyout2025 · 1yr€1.0B0 active
No portfolio companies tracked yet.
Armira Growth Fund IGrowth2021 · 5yr€200M10 active
Unrealized
10 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Mobility |  Austria | 2026 | |
| Cybersecurity |  Germany | 2025 | |
| Data & Analytics |  Switzerland | 2025 | |
| HealthTech | Austria | 2026 | |
| Software | Germany | 2023 | |
| AI/ML | Germany | 2025 | |
| Aerospace & Defence | Germany | 2026 | |
| Mobility | Germany | 2022 | |
| HR Tech | Germany | 2022 | |
| HR Tech | Germany | 2022 |
Austria· Entry 2026Germany· Entry 2025Switzerland· Entry 2025Austria· Entry 2026Germany· Entry 2023Germany· Entry 2025Germany· Entry 2026Germany· Entry 2022Germany· Entry 2022Germany· Entry 2022Armira EvergreenEvergreenActive2008 · 18yr€5.0B13 active · 6 realized
Unrealized
13 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Pharma | Germany | 2024 | |
| Consumer | Germany | 2023 | |
| AdTech | Germany | 2023 | |
| Software | Switzerland | 2018 | |
| Aerospace & Defence | Germany | 2024 | |
| IT Services | Germany | 2023 | |
| MedTech | Germany | 2025 | |
| Healthcare | Germany | 2021 | |
| Pharma | Greece | 2024 | |
| IT Services | Germany | 2021 | |
| MedTech | Germany | 2019 | |
| E-commerce | Germany | 2024 | |
| Hospitality |  Netherlands | 2026 |
Germany· Entry 2024Germany· Entry 2023Germany· Entry 2023Switzerland· Entry 2018Germany· Entry 2024Germany· Entry 2023Germany· Entry 2025Germany· Entry 2021Germany· Entry 2021Germany· Entry 2019Germany· Entry 2024Netherlands· Entry 2026Realized
6 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Business Services | Germany | 2018 | 2025 | Secondary | – | ||
| Consumer | Germany | 2019 | 2021 | IPO | – | ||
| Aerospace & Defence | Germany | 2016 | 2024 | Trade Sale | – | ||
| Industrials | Germany | 2022 | 2025 | Trade Sale | – | ||
| SaaS | Germany | 2017 | 2020 | Secondary | – | ||
| Aerospace & Defence | Germany | 2014 | 2020 | Secondary | – |
Saved GPs appear in your watchlist, one click from your workspace.
Investment team
Senior partners. Hand-checked from public filings and the firm's own site.
Similar firms
Other private equity firms tracked on GP Intel.
Germany·€5.0B
Germany·€5.0B
Germany·€6.5B
Germany·€7.0B
Germany·€3.0B
Germany·€3.0B
Germany·€3.0B
Germany·€2.8B
Germany·€2.7B
Germany·€2.7B
Germany·€7.5B
Germany·€2.5BGet the full picture on Armira.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in